openPR Logo
Press release

Carcinoembryonic Antigen (CEA) Market Prominent Players – F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biological Technology

02-11-2019 12:04 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Carcinoembryonic Antigen Market

Carcinoembryonic Antigen Market

Carcinoembryonic Antigen Market size is set to reach USD 3.0 billion by 2024; according to a new research study published by Global Market Insights, Inc.

Rising geriatric population base coupled with growing number of cancer diseases is driving the carcinoembryonic antigen market size over the forecast timeframe. According to the World Health Organization, cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018. Additionally, worldwide, about 1 in 6 deaths is due to cancer. All these factors will propel the global market growth.

Constant advancement in technology such as proteomics that includes mass spectrometry, protein bioinformatics, protein labelling, imaging and array-based approaches with the development of new biomarkers that can be used in combination with other biomarkers is anticipated to fuel the demand for carcinoembryonic antigen market growth during the forecast timeframe. Favorable government initiatives for the improvement of diagnostic rates and the advancement of new combination biomarkers has immense growth opportunities for carcinoembryonic antigen market. Hence, it will result in increasing demand for effective carcinoembryonic antigen tests, thereby fueling business growth.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/427

The inability of carcinoembryonic antigen tests to detect early stage cancer will be a major market impeding factor. In addition, lack of awareness regarding the application of carcinoembryonic antigen tests will decrease the demand, thus hindering the market growth.

Gastrointestinal cancer market was valued around USD 652.4 million in the year 2017. According to an article published in the National Center for Biotechnology Information, gastrointestinal cancer is the fourth most common malignancy worldwide and remains the second most common cause of death of all malignancies globally, hence driving the market growth for carcinoembryonic antigen.

Breast cancer market is estimated to grow at a CAGR of 7.3% over the projection period. Breast cancer is the most common cancer affecting the women population. Furthermore, breast cancer diagnosis involves three tumor markers, one of them being carcinoembryonic antigen; carcinoembryonic antigen tests have been used to help monitor metastatic breast cancer (advanced disease), that will propel the industry growth in the forthcoming years.

Males in carcinoembryonic antigen market was valued around USD 1,003.2 million in the year 2017. The rationale for greater market share in men carcinoembryonic antigen market is the greater frequency of cancer diagnosis, rather than poorer survival once the cancer is diagnosed at a late stage. Furthermore, lifestyle-related factors such as smoking, drinking increasing amounts of alcohol, putting on weight, and taking less exercise are also responsible for the largest share of males in carcinoembryonic antigen market.

The hospitals market is projected to grow at a considerable CAGR of 6.1% over the forecast timeframe owing to increasing number of hospital admissions. Geriatric population suffering from cancers requiring continuous monitoring prefer minimally invasive procedures carried out in hospitals and clinics, that will boost the market growth.

U.S. market is estimated to grow at robust CAGR of 6.0% during the projection period. Increase in number of geriatric population affected with cancer, advancements in carcinoembryonic antigen tests, greater patient and physician awareness regarding early disease detection and availability of low-cost tests across broader settings of care are some of the major factors contributing to largest market share in the region.

Japan dominated the Asian market and was valued around USD 74.6 million in the year 2017. Growing awareness about pre-disease diagnosis and prevention will further drive the market growth. Additionally, rising per capita healthcare expenditure and growing demand for rapid and cost effective carcinoembryonic antigen tests will fuel the market growth in Japan.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/427

Some of the leading players in the carcinoembryonic antigen market include F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biological Technology. These companies opt for strategic decisions such as mergers, acquisitions, and partnerships in order to increase their efficiency and sustain in the market.

Carcinoembryonic antigen market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:
Carcinoembryonic antigen (CEA) market by Application
• Gastrointestinal Cancer
o Colon Cancer
o Pancreatic Cancer
o Rectal Cancer
o Liver Cancer
o Stomach Cancer
o Esophageal Cancer
o Gallbladder Cancer
o Anal Cancer
• Breast Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer
• Thyroid Cancer
Carcinoembryonic antigen (CEA) market by Gender
• Male
• Female
Carcinoembryonic antigen (CEA) market by End-user
• Hospitals
• Diagnostic Centers
• Cancer Centers
• Research and Academic Institutes
• Others
The above information is provided for the following regions/countries:
• North America
o U.S.
o Canada
• Europe
o Germany
o UK
o France
o Spain
o Italy
o Poland
o Russia
o Sweden
o Switzerland
o Netherlands
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o New Zealand
o Malaysia
o Singapore
o Indonesia
o Philippines
• Latin America
o Brazil
o Mexico
o Argentina
o Columbia
o Peru
• Middle East and Africa
o South Africa
o Saudi Arabia
o UAE

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carcinoembryonic Antigen (CEA) Market Prominent Players – F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biological Technology here

News-ID: 1576511 • Views: 377

More Releases from Global Market Insights, Inc.

Global sodium metasilicate pentahydrate market size by 2025 | Top Companies are …
Global Market Insights, Inc., says that sodium metasilicate pentahydrate market may exceed USD 875 million by 2025. Sodium metasilicate pentahydrate market is expected to accrue momentous proceeds from the cement industry. The product is used as a connecting agent in the making of refractory cement & can enable properties such as chemical and heat resistance and hardness. It has also found application in the cosmetic, textile, ceramics, chemical production, and
Vinyl ester market Growth in Europe, Impact Covid19 and Top key players like Swa …
Vinyl ester market to be fueled by increasing deployment of wind energy facilities, Europe to emerge as a pivotal revenue pocket. In 2017, Europe marked a growth of 25% in the wind power plant capacity annual installation as compared to 2016. Whereas wind energy was the second-largest source of power generation power in the year 2016 in Europe. Nations worldwide are actively aligning their focus toward the deployment of wind
Biaxially Oriented Polypropylene (BOPP) Market Size, Share by key players like B …
Biaxially oriented polypropylene (BOPP) market size to reach USD 20 billion by 2024. Growing focus on superior packaging for the protection of delicate good, foods, medicines, and others will favor BOPP business growth in the coming years. Rapid proliferation of e-commerce platforms along with changing consumer spending trends will drive biaxially oriented polypropylene (BOPP) market outlook. In a world of constantly-changing lifestyles, consumers expect products to be shatter-proof, lightweight, aesthetically appealing,
Titanium Dioxide Market to see 7%+ CAGR over 2021-2026 | Key Players are Tronox …
Titanium Dioxide Market growth will be driven by rising expansion activities in the paints & coatings sector and proliferating application in paper & pulp industry. For years, titanium dioxide (TiO₂) has been used in the manufacturing of numerous consumer products across various industries. The product finds applications in paints, adhesives, coatings, paper, rubber, printing inks, textiles, coated fabrics, ceramics, roofing materials, floor coverings, and cosmetics. Surging in product demand across

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,